Published November 27, 2014 | Version v1
Patent Open

ANTIBODIES DIRECTED AGAINST INFLUENZA

Description

Antibodies that specifically bind influenza virus hemagglutinin A (HA), and antigen binding fragments thereof are disclosed herein. In several embodiments, these antibodies are broadly neutralizing. Nucleic acids encoding these monoclonal antibodies, vectors including these nucleic acids, and host cells transformed with these vectors are also disclosed. Compositions are disclosed that include these antibodies, antigen binding fragments, nucleic acids, vectors and host cells. Method of using these antibodies, and antigen binding fragments, nucleic acids, vectors and host cells, such as for diagnosis and treatment of an influenza virus infection are also provided.

Files

US20140348851.pdf

Files (9.3 MB)

Name Size Download all
md5:bd74da60e9140b4662698bc5e2962d13
9.3 MB Preview Download

Additional details

Identifiers

Patent number
US 201214350632 A
Patent application number
US 2014/0348851 A1
Other
oai:uchicago.tind.io:7858

Dates

Patent filed
2012-10-18

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Immunology